Skip to content
TrialScanner

NCT05107856

PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies

Phase 1TerminatedPRLDLead

Registry record

Lead sponsor
Prelude Therapeutics Incorporated
Conditions
Acute Myeloid Leukemia; B-cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myelomonocytic Leukemia; Follicular Lymphoma
Primary completion
Jan 19, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05107856 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05107856: PRT1419 as Monotherapy or in... | TrialScanner